First Light Acquisition Group, Inc.
Status: Deal Closed
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $230.00M |
---|---|
IPO Date | Sep 10, 2021 |
CEO | Thomas A. Vecchiolla |
Left Lead | Guggenheim Securities |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 12 + 3 + 3 + 3 + 3 |
IPO Sector |
Technology
Companies that provide technology-enabled solutions with high-growth, mission-critical applications in government and commercial markets |
IPO Geography | Global |
Target Company | Calidi Biotherapeutics |
Deal Announced | Jan 9, 2023 |
Deal Size, $M | $335.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Aug 28, 2023 |
Amendment Vote | Sep 13, 2022 |
Closing Date | Sep 12, 2023 |
Formerly FLAG
CLDI
CLDI/W
Price | $0.16 |
---|---|
Last closing price | $0.17 |
H/L, today | $0.15 / $0.17 |
H/L, 52-week | $1.50 / $5.00 |
Volume, today | 939,758 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | $0.08 |
---|---|
Last closing price | $0.08 |
High/low price, today | $0.08 / $0.08 |
Volume, today | 599 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on First Light Acquisition Group, Inc.:
- Structure and cap table
- 5 directors & officers
- 39 filings and events
- 2 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Thomas A. Vecchiolla | 66 | CEO, President, Chairman and Director |
Michael J. Alber | 64 | CFO and Secretary |
Michael C. Ruettgers | 78 | Lead Independent Director |
William J. Fallon | 76 | Independent Director |
Jeanne C. Tisinger | 59 | Independent Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Guggenheim Securities | BR | 20,000,000 | units |
BTIG | 0 | ||
20,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 39 filings.